Arcus Biosciences, Inc.
RCUS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001724521
In the last 90 days, Arcus Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 243 institutions reported holding it in 13F filings for Q3 2026, worth $3.23B in total; no superinvestor holds it.
Holders of 5% or more of RCUS
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Arcus Biosciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 13D/A | 24.70%31.4M shares | −0.90 ppfrom 25.60% | Feb 2, 20218 filings | Aug 7, 2026 | SEC |
| BlackRock, Inc. | 13G/A | 10.40%12.7M shares | +1.00 ppfrom 9.40% | Oct 23, 20244 filings | Jan 8, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
40 Schedule 13D and 13G filings on Arcus Biosciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 20264:30 PM ET | Gilead Sciences, Inc. | 13D/A | 24.70%31.4M shares | −0.90 ppfrom 25.60% | Aug 5, 2026 | SEC |
| Mar 26, 20263:45 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Jan 8, 20261:28 PM ET | BlackRock, Inc. | 13G/A | 10.40%12.7M shares | +1.00 ppfrom 9.40% | Dec 31, 2025 | SEC |
| Nov 14, 20254:07 PM ET | Point72 Asset Management, L.P.and 2 others | 13G/A | 4.10%4.33M shares | −1.40 ppfrom 5.50%Below 5% | Sep 30, 2025 | SEC |
| Nov 5, 20255:19 PM ET | Gilead Sciences, Inc. | 13D/A | 25.60%31.4M shares | −4.10 ppfrom 29.70% | Nov 3, 2025 | SEC |
| Jul 15, 20257:46 PM ET | Gilead Sciences, Inc. | 13D/A | 29.70%31.4M shares | −5.30 ppfrom 35.00% | Jul 13, 2025 | SEC |
| May 13, 20255:57 PM ET | Point72 Asset Management, L.P.and 2 others | 13G | 5.50%5.83M shares | New | May 12, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 9.40%9.98M shares | – | Mar 31, 2025 | SEC |
| Mar 5, 20255:00 PM ET | Gilead Sciences, Inc. | 13D/A | 35.00%39.7M shares | 0.00 ppfrom 35.00% | Feb 18, 2025 | SEC |
| Feb 20, 20257:43 PM ET | Gilead Sciences, Inc. | 13D/A | 35.00%39.7M shares | – | Feb 18, 2025 | SEC |
| Dec 17, 2024 | Rosen Terry J | 13D/AOld format | – | – | – | SEC |
| Nov 12, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 23, 2024 | BlackRock, Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 17, 2024 | State Street Corp | 13G/AOld format | – | – | – | SEC |
| Feb 13, 2024 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | FMR LLC | 13GOld format | – | New | – | SEC |
| Jan 31, 2024 | Gilead Sciences, Inc. | 13D/AOld format | – | – | – | SEC |
| Jan 24, 2024 | State Street Corp | 13GOld format | – | New | – | SEC |
| Jan 23, 202411:52 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jul 6, 2023 | Gilead Sciences, Inc. | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | PFM Health Sciences, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Biotechnology Value Fund L P | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2023 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13GOld format | – | New | – | SEC |
| Jan 26, 20238:43 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Jan 20, 20239:43 AM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Oct 17, 2022 | PFM Health Sciences, LP | 13GOld format | – | – | – | SEC |
| May 9, 20223:23 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Mar 14, 2022 | Biotechnology Value Fund L P | 13GOld format | – | New | – | SEC |
| Feb 14, 2022 | GV 2016, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | PFM Health Sciences, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | EcoR1 Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 4, 20224:12 PM ET | BlackRock Inc. | 13GOld format | – | – | – | SEC |
| Jul 19, 2021 | EcoR1 Capital, LLC | 13GOld format | – | New | – | SEC |
| Mar 9, 20216:33 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Boxer Capital, LLC | 13G/AOld format | – | – | – | SEC |
| Feb 16, 2021 | PFM Health Sciences, LP | 13G/AOld format | – | – | – | SEC |
| Feb 2, 20212:56 PM ET | BlackRock Inc. | 13GOld format | – | New | – | SEC |
| Feb 2, 2021 | Gilead Sciences, Inc. | 13D/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
50 notices from officers, directors and other affiliates planning to sell Arcus Biosciences, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Aug 21, 20264:36 PM ET | Alexander AzoyOfficer | 2.83K | $83.5K | Aug 21, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 9, 20266:31 PM ET | Juan JaenOfficer | 25.0K | $749.0K | Jul 9, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jun 24, 20266:17 PM ET | Juan JaenOfficer | 50.0K | $1.44M | Jun 24, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jun 22, 20266:31 PM ET | Juan JaenOfficer | 25.0K | $680.8K | Jun 22, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Jun 1, 20264:26 PM ET | Alexander AzoyOfficer | 2.56K | $64.9K | Jun 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 11, 20265:33 PM ET | Robert C. Goeltz IIOfficer | 7.76K | $199.0K | May 11, 202610b5-1 | Merrill Lynch | SEC |
| May 6, 20264:11 PM ET | Jennifer JarrettOfficer | 77.8K | $1.91M | May 6, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 23, 20264:46 PM ET | Jennifer JarrettOfficer | 53.8K | $1.36M | Apr 23, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 8, 20264:21 PM ET | Jennifer JarrettOfficer | 70.0K | $1.58M | Apr 8, 2026 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 5, 20264:58 PM ET | Juan JaenOfficer | 31.8K | $692.8K | Jan 5, 202610b5-1 | Goldman Sachs & Co. LLC | SEC |
| Dec 31, 20256:26 PM ET | Robert C. Goeltz IIOfficer | 6.55K | $153.2K | Dec 31, 202510b5-1 | Merrill Lynch | SEC |
| Dec 18, 20254:23 PM ET | Alexander AzoyOfficer | 4.34K | $96.8K | Dec 18, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 15, 20256:23 PM ET | Richard MarkusOfficer | 10.0K | $219.0K | Dec 16, 202510b5-1 | E*TRADE FINANCIAL CORPORATION | SEC |
| Dec 15, 20256:22 PM ET | Carolyn TangOfficer | 15.0K | $328.5K | Dec 16, 202510b5-1 | E*TRADE FINANCIAL CORPORATION | SEC |
| Dec 15, 20256:22 PM ET | Alexander AzoyOfficer | 5.00K | $109.5K | Dec 16, 202510b5-1 | E*TRADE FINANCIAL CORPORATION | SEC |
| Dec 15, 20256:21 PM ET | Robert C. Goeltz, IIOfficer | 14.0K | $306.6K | Dec 16, 202510b5-1 | E*TRADE FINANCIAL CORPORATION | SEC |
| Dec 15, 20256:21 PM ET | Jennifer JarrettOfficer | 22.0K | $481.8K | Dec 16, 202510b5-1 | E*TRADE FINANCIAL CORPORATION | SEC |
| Dec 15, 20256:20 PM ET | Juan JaenOfficer | 22.0K | $481.8K | Dec 16, 202510b5-1 | E*TRADE FINANCIAL CORPORATION | SEC |
| Dec 15, 20256:19 PM ET | Terry Rosen, Ph.D.Officer · Director | 55.0K | $1.20M | Dec 16, 202510b5-1 | E*TRADE FINANCIAL CORPORATION | SEC |
| Dec 4, 20255:10 PM ET | Juan JaenOfficer | 83.0K | $2.10M | Dec 4, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| Nov 26, 20254:20 PM ET | Alexander AzoyOfficer | 1.90K | $46.1K | Nov 26, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 26, 20253:12 PM ET | Robert C. Goeltz IIOfficer | 5.00K | $125.0K | Nov 26, 202510b5-1 | Merrill Lynch | SEC |
| Nov 17, 20256:27 PM ET | Juan JaenOfficer | 50.0K | $999.5K | Nov 17, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| Oct 30, 20256:21 PM ET | Juan JaenOfficer | 1.17K | $23.7K | Oct 30, 202510b5-1 | Goldman Sachs & Co. LLC | SEC |
| Oct 28, 20257:02 PM ETAmended | Robert C. Goeltz IIOfficer | 5.00K | $100.0K | Oct 28, 202510b5-1 | Merrill Lynch | SEC |
Showing the latest 25. See the RCUS notices from the last 12 months